)
CytoDyn (CYDY) investor relations material
CytoDyn Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
The 2026 Annual Meeting will be held virtually on November 20, 2026, with voting eligibility for shareholders of record as of September 24, 2026.
Shareholders will vote on electing five directors, ratifying the independent auditor, and approving executive compensation on an advisory basis.
The Board recommends voting in favor of all proposals and nominees.
Voting matters and shareholder proposals
Proposals include electing five directors, ratifying CBIZ CPAs P.C. as auditor for fiscal 2027, and approving executive compensation.
All proposals are advisory except for the director elections.
Shareholders may submit proposals for the 2027 meeting between July 23 and August 22, 2027.
Board of directors and corporate governance
The Board consists of five independent directors, each serving on key committees: Audit, Compensation, and Nominating/Governance.
Board Chair is Tanya D. Urbach, an independent director.
Board members attended at least 75% of meetings in fiscal 2026.
The Board values diversity, with two female and one racially/ethnically diverse director among nominees.
- Registering 794.9M shares for resale, with proceeds only from warrant exercises and high risk factors.CYDY
Registration filing - Leronlimab demonstrates promising efficacy and safety in advanced cancer trials, with key milestones ahead.CYDY
Life Sciences Virtual Investor Forum Conference - Net loss of $42.7M, ongoing liquidity risks, and urgent need for new funding despite clinical progress.CYDY
Q4 2026 - Promising phase II data and rapid enrollment highlight strong momentum for leronlimab in oncology.CYDY
16th Annual LD Micro Invitational Conference - Leronlimab shows robust ctDNA declines and tumor control in advanced colorectal cancer.CYDY
Study update - Clinical-stage biotech registers 278M shares for resale; future hinges on leronlimab and new funding.CYDY
Registration filing - Quarterly net loss of $4.7M, major notes extended, and ongoing going concern risk persists.CYDY
Q3 2026 - Net loss of $22.6 million and legal settlement accrual raise going concern risks.CYDY
Q2 2026 - All director nominees and proposals were preliminarily approved at the 2024 annual meeting.CYDY
AGM 2024
Next CytoDyn earnings date
Next CytoDyn earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)